Winrevair 45MG INJ

Ended Awarded

Contract number
36C26126N0243
Awardee
Awarding agency
Obligated
$20,994

Award facts

Contract value 100% obligated
$20,993.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Rahway, NJ 07065, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order to Merck Sharp & Dohme LLC for WINREVAIR 45 mg injection with a ceiling value of $20,993.84. This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of January 9, 2026, represents a child contract under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The award was not designated as a set-aside and will be performed at Merck's facility in Rahway, New Jersey.

As a major pharmaceutical supplier to federal agencies, Merck has leveraged its position on the VA's $5.8 billion Federal Supply Schedule for pharmaceuticals and related products to fulfill this delivery order for the injectable medication. This contract award exemplifies the VA's procurement approach for specialized pharmaceutical treatments needed to support veteran healthcare initiatives through the Veterans Integrated Service Network system.

Quick answers

Who was awarded contract 36C26126N0243?

36C26126N0243 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on December 9, 2025.

How much is contract 36C26126N0243 worth?

The government has obligated $20,994 on 36C26126N0243.

Is contract 36C26126N0243 an order under another contract?

Yes. 36C26126N0243 is a delivery order under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26126N0243 competed?

The extent of competition for 36C26126N0243 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award